Trends of Immunosuppression Therapy and Their Effectiveness in Patients With Liver Transplantation
Specific aims are proposed to achieve in this study:
1. To compare graft and patient survival rate, incidence of treatment-related adverse
effects between different patterns of immunosuppression combination among patients
received post-liver transplant care in Kaohsiung Chang Gung Memorial Hospital (KCGMH),
Taiwan.
2. To quantify the long-term health impacts of immunosuppressive regimens on
quality-adjusted life expectancy (QALE), the loss-of-QALE relating to immunosuppression
therapy, and types of transplantation.
Aim 1:
Observational
Observational Model: Cohort
incidence of graft and patient mortality, treatment-related complications
Patient will be followed from the date of liver transplantation to the occurence of outcome event for 5 years
5 years
Yes
Chien-Ning Hsu, PhD
Principal Investigator
Kaohsiung Chang Gung Memorial Hospital
Taiwan : Food and Drug Administration
102-0582C
NCT01834690
April 2013
December 2014
Name | Location |
---|